Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11352955rdf:typepubmed:Citationlld:pubmed
pubmed-article:11352955lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0239307lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0029246lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0035168lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0079459lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C1185740lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0013089lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0025677lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0042670lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0065452lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0282461lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0442711lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0439658lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0439858lld:lifeskim
pubmed-article:11352955lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:11352955pubmed:issue10lld:pubmed
pubmed-article:11352955pubmed:dateCreated2001-5-15lld:pubmed
pubmed-article:11352955pubmed:abstractTextThis randomized trial evaluated antitumor activity of and survival asociated with high-dose-intensity chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) plus granulocyte colony-stimulating factor (HD-MVAC) versus MVAC in patients with advanced transitional-cell carcinoma (TCC).lld:pubmed
pubmed-article:11352955pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11352955pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11352955pubmed:languageenglld:pubmed
pubmed-article:11352955pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11352955pubmed:citationSubsetIMlld:pubmed
pubmed-article:11352955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11352955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11352955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11352955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11352955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11352955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11352955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11352955pubmed:statusMEDLINElld:pubmed
pubmed-article:11352955pubmed:monthMaylld:pubmed
pubmed-article:11352955pubmed:issn0732-183Xlld:pubmed
pubmed-article:11352955pubmed:authorpubmed-author:FossaS DSDlld:pubmed
pubmed-article:11352955pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:11352955pubmed:authorpubmed-author:SpinaMMlld:pubmed
pubmed-article:11352955pubmed:authorpubmed-author:ThéodoreCClld:pubmed
pubmed-article:11352955pubmed:authorpubmed-author:SternbergC...lld:pubmed
pubmed-article:11352955pubmed:authorpubmed-author:SchornagelJ...lld:pubmed
pubmed-article:11352955pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:11352955pubmed:authorpubmed-author:de MulderP...lld:pubmed
pubmed-article:11352955pubmed:authorpubmed-author:CollettiPPlld:pubmed
pubmed-article:11352955pubmed:authorpubmed-author:WitjesFFlld:pubmed
pubmed-article:11352955pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:11352955pubmed:authorpubmed-author:European...lld:pubmed
pubmed-article:11352955pubmed:issnTypePrintlld:pubmed
pubmed-article:11352955pubmed:day15lld:pubmed
pubmed-article:11352955pubmed:volume19lld:pubmed
pubmed-article:11352955pubmed:ownerNLMlld:pubmed
pubmed-article:11352955pubmed:authorsCompleteYlld:pubmed
pubmed-article:11352955pubmed:pagination2638-46lld:pubmed
pubmed-article:11352955pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:meshHeadingpubmed-meshheading:11352955...lld:pubmed
pubmed-article:11352955pubmed:year2001lld:pubmed
pubmed-article:11352955pubmed:articleTitleRandomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924.lld:pubmed
pubmed-article:11352955pubmed:affiliationVincenzo Pansadoro Foundation, Rome, Italy. cstern@mclink.itlld:pubmed
pubmed-article:11352955pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11352955pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:11352955pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11352955pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:11352955pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:11352955pubmed:publicationTypeClinical Trial, Phase IIIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11352955lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11352955lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11352955lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11352955lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11352955lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11352955lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11352955lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11352955lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11352955lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11352955lld:pubmed